China's SASAC Orders State Enterprises to Accelerate R&D and Investment Under 15th Five-Year Plan

Highlights

• China's SASAC directed central state-owned enterprises to accelerate investment and research under the 2026–2030 Five-Year Plan amid rising US-China trade tensions.
• China controlled 91% of magnet rare earth refining and 94% of sintered permanent magnet production in 2024, giving Beijing leverage over Western supply chains.
• Chinese-origin assets accounted for 50% of major global pharmaceutical licensing deals in Q1 2026, signaling China's expanding innovation reach beyond minerals.
• Beijing's industrial advantage combines processing expertise, manufacturing scale, scientific investment, and coordinated state policy rather than mineral possession alone.